The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.
Autism researchers can’t agree on how far to go to validate the input they gather from minimally verbal autistic people who use certain communication devices.
The New York State Psychiatric Institute in New York City is undergoing an audit and a change in leadership following a suicide that occurred during one of its clinical trials.
The paper marks the second retraction for one of the co-authors.
The retracted studies mar hope for the drug’s use in depression.
Genes exert their strongest influence on the brain in the first half of gestation — a key window for autism and other neurodevelopmental conditions.
The result raises hopes for an ongoing clinical trial in people — and offers fresh insight into the biology of imprinting and the UBE3A antisense transcript.
A machine-learning technique applied to brain imaging data appears to predict a person’s mix of verbal intelligence, social affect and repetitive behaviors.
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.
Parents say the so-called ‘rapid prompting method’ unlocks hidden talents in their minimally verbal autistic children, but researchers question whether the words produced are the child’s own.
